Cindy Wade
Acute Care · Abington, PANPI 1013672849
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,389, 6.0 times the $230 reported in 2023. Among acute care clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $28.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$348
- Pfizer$344
- AstraZeneca$315
- Novo Nordisk$229
- Lilly USA, LLC$201
- AbbVie$150
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,605100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $348 |
| Pfizer | 10 | $344 |
| AstraZeneca | 12 | $315 |
| Novo Nordisk | 10 | $229 |
| Lilly USA, LLC | 10 | $201 |
| AbbVie | 4 | $150 |
| Amgen | 3 | $146 |
| Inspire Medical Systems, Inc. | 6 | $117 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Almatica Pharma LLC | 6 | $105 |
| Astellas Pharma US Inc | 3 | $93 |
| Electromed, Inc. | 1 | $76 |
| Phathom Pharmaceuticals, Inc. | 2 | $61 |
| Lundbeck LLC | 2 | $53 |
| Exact Sciences | 2 | $51 |
| Dexcom, Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Eisai Inc. | 1 | $26 |
| Bayer | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Merck | 1 | $20 |
| Intra-sana Laboratories | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,605 in reported general payments places this provider in the 90th percentile of 872 acute care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 18 | $168 |
| Atorvastatin Calcium | 12 | $110 |
| Levofloxacin | 15 | $54 |
| Prednisone | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other acute care in Abington
- Kevin HaganAbington$17K
- Kelly ApplebaumAbington$14K
- Kristi MontrellaAltoona$111K
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Donna KinzlerPittsburgh$25K
- Lisa JohnsonPottstown$25K
- Kathryn McParlaneMoon Township$21K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.